What is it about?
Clinical management of BTcP is still not satisfactory despite the availability of effective pharmacological agents. This review presents an overview of the appropriate and inappropriate actions to take in the diagnosis and treatment of BTcP
Featured Image
Why is it important?
Five ‘things to do’ and five ‘things not to do’ in the diagnosis and treatment of BTcP are proposed, and evidence supporting said recommendations are described
Perspectives
This review presents an overview of the appropriate and inappropriate actions to approach BTcP
renato vellucci
Read the Original
This page is a summary of: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion, Drugs, January 2016, Springer Science + Business Media,
DOI: 10.1007/s40265-015-0519-2.
You can read the full text:
Contributors
The following have contributed to this page
